beta-lapachone has been researched along with Carcinoma, Ehrlich Tumor in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queiroz, ML | 1 |
| Valadares, MC | 1 |
| Torello, CO | 1 |
| Ramos, AL | 1 |
| Oliveira, AB | 1 |
| Rocha, FD | 1 |
| Arruda, VA | 1 |
| Accorci, WR | 1 |
1 other study available for beta-lapachone and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Comparative studies of the effects of Tabebuia avellanedae bark extract and beta-lapachone on the hematopoietic response of tumour-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Carcinoma, Ehrlich Tumor; Chromatogra | 2008 |